Compare JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Nasdaq Equity Premium Income ETF vs Tenet Healthcare Corporation — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $61.09 (market cap $44.49B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 2.1× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 5,681,789). Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Nasdaq Equity Premium Income ETF for 66 Days and Tenet Healthcare Corporation for 15 Days on average.
| JEPQ | THC | |
|---|---|---|
Market Cap | $44.49B | $20.98B |
Volume | 5,681,789 | 428,008 |
Sector | Income / Options Overlay | Health |
52-Week High | $61.46 | $280.77 |
52-Week Low | $53.77 | $161.37 |
Typical Hold Time | 66 Days | 15 Days |
Enterprise Value | — | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPQ trades at $60.93, down 0.55% on the day, with a bullish technical signal from moving averages while oscillators remain neutral. The ETF's covered-call strategy generates substantial monthly income, with recent dividends ranging from $0.57 to $0.70 per share. Recent news highlights JEPQ's 11% estimated annual yield and its positioning in AI-driven tech stocks, though the strategy limits upside potential during strong market rallies.
JEPQ offers high income generation through its Nasdaq-focused covered-call approach, making it attractive for retirees seeking monthly cash flow. However, the strategy caps appreciation potential and faces volatility sensitivity, requiring proper portfolio sizing. Key risks include market volatility dependence and competitive pressure from similar income ETFs with different tax treatments.
Tenet Healthcare (THC) trades at $260.57, up 0.28% with strong technical momentum and bullish moving averages. The stock demonstrates robust fundamentals with consistent earnings beats, a 10.07 P/E ratio, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 earnings scheduled for October 29. Technical indicators show support at $257 and resistance at $262, with overall bullish sentiment from analysts.
THC presents a compelling investment case with strong profitability metrics and analyst consensus pointing to 8.7% upside to the $283.36 price target. Key risks include declining net cash flow and potential surgical volume pressures. The combination of value pricing, earnings momentum, and institutional support suggests continued upward potential, though investors should monitor cash flow sustainability and Q3 earnings results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
